CLEANTASTE
DEAD

Serial Number

75525503

Owner

Mayne Pharma International Pty Ltd

Attorney

David C. Gryce

Filing Date

Jul 27, 1998

Add to watchlist:

No watchlists yet
View on USPTO

CLEANTASTE Trademark

Serial Number: 75525503 • Registration: 2468719

CLEANTASTE is a trademark filed by Mayne Pharma International Pty Ltd on July 27, 1998. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Mayne Pharma International Pty Ltd (22 trademarks)

Salisbury South, SA 5106 , AU

Entity Type: 77

F.H. FAULDING & CO. LIMITED (21 trademarks)

NORTH ADELAIDE, SOUTH AUSTRALIA , AU

Entity Type: 11

Trademark Details

Filing Date

July 27, 1998

Registration Date

July 17, 2001

Published for Opposition

April 24, 2001

Cancellation Date

April 19, 2008

Goods & Services

Taste masked pharmaceutical goods, namely anaesthetics; anti-cancer drugs; anti-parasitic preparations; anti-infectives; anti-ulcer drugs; amino acids and peptides; anabolic drugs; analgesics; antacids; anti-helminties and schistosomicides; anti-anginal drugs; anti-arrhythmic; anti-asthmatics; anti-coagulants and anti-thrombotic drugs; anti-convulsants; anti-depressants; anti-diarrhea preparations; anti-emetics; anti-histamines; anti-hypertensive drugs; anti-inflammatory substances; anti-invectives; anti-maniacs; anti-nauseates; anti-obesity drugs; anti-oxidants; anti-pyrites; anti-spasmodics; antibiotics; anticholinergic; appetite suppressants; bronchodilators; cerebral dilators; coronary dilators; corticosteroids; cough suppressants; decongestants; digestives; diuretics; erythropoietic drugs; evacuants; expectorants; gastro-intestinal preparations; gastro-intestinal sedatives; hormones; hyperglycaemic agents; hypoglycaemic agents; hypnotics; laxatives; minerals; mucolytics and anti-uricemic drugs; muscle relaxants; neuromuscular drugs; prostaglandins; psychrotropic; pain relievers; soporifics; sedatives; steroids; stimulants; thyroid preparations and anti-thyroid preparations; uterine relaxants, vasoconstrictors and migraine treatments; vasodilators; vitamins; neuroleptic drugs; central nervous stimulants; drugs used in the treatment of migraine; anti-epileptic drugs; substances used in the treatment of diabetes; antiseptics; haemopoietic drugs and uricosuric drugs

Filing History

CANCELLED SEC. 8 (6-YR)
Apr 19, 2008 C8..
CASE FILE IN TICRS
Feb 22, 2007 CFIT
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 30, 2006 ASGN
REGISTERED-PRINCIPAL REGISTER
Jul 17, 2001 R.PR
PUBLISHED FOR OPPOSITION
Apr 24, 2001 PUBO
NOTICE OF PUBLICATION
Apr 11, 2001 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 22, 2000 CNSA
Sec. 1(B) CLAIM DELETED
Nov 14, 2000 1.BD
EXAMINER'S AMENDMENT MAILED
Nov 14, 2000 CNEA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 10, 2000 CRFA
FINAL REFUSAL MAILED
Jan 18, 2000 CNFR
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 19, 1999 CRFA
NON-FINAL ACTION MAILED
Apr 26, 1999 CNRT
ASSIGNED TO EXAMINER
Mar 23, 1999 DOCK